EBV reactivation serological profile in primary Sjögren's syndrome: An underlying trigger of active articular involvement?

Rheumatology International

Volumn 33, Issue 5, 2013, Pages 1149-1157

  Pasoto, Sandra Gofinet ^a   Natalino, Renato Romera ^a   Chakkour, Henrique Pires ^a   Viana, Vilma Dos Santos Trindade ^a   Bueno, Cleonice ^a   Leon, Elaine Pires ^a   Vendramini, Margarete Borges Gualhardo ^a   Neto, Mauricio Levy ^a   Bonfa, Eloisa ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti EBV early antigen diffuse; EBV early antigen diffuse; Epstein Barr virus; Human T leukemia virus 1; Primary Sj gren's syndrome

Indexed keywords

ANTIBODY; CHLOROQUINE; CYCLOSPORIN; EARLY ANTIGEN; EARLY ANTIGEN DIFFUSE ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN 1; FODRIN; GLUCOCORTICOID; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS REACTION; CRYOGLOBULINEMIA; DISEASE ACTIVITY; DISEASE DURATION; EPSTEIN BARR VIRUS; EULAR SJOGREN SYNDROME DISEASE ACTIVITY INDEX; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HYPERGAMMAGLOBULINEMIA; HYPOCOMPLEMENTEMIA; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SJOEGREN SYNDROME; VIRUS REACTIVATION;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOCORTICOIDS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; JOINTS; MALE; MIDDLE AGED; PREDNISONE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; VIRUS ACTIVATION;

EID: 84878015344     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2504-3     Document Type: Article

References (46)

1. Tzioufas AG, Voulgarelis M (2007) Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol 21:989-1010
2. Amarasena R, Bowman S (2007) Sjögren's syndrome. Clin Med 7:53-56
3. García-Carrasco M, Ramos-Casals M, Rosas J et al (2002) Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine 81:270-280
4. Nardi N, Brito-Zerón P, Ramos-Casals M et al (2006) Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome. Prevalence and clinical significance in 335 patients. Clin Rheumatol 25:341-346
5. Routsias JG, Tzioufas AG (2007) Sjögren's syndrome- study of autoantigens and autoantibodies. Clinic Rev Allerg Immunol 32:238-251
6. Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554-558
7. James JA, Harley JB, Scofield RH (2001) Role of viruses in systemic lupus erythematosus and Sjögren syndrome. Curr Opin Rheumatol 13:370-376
8. Toussirot E, Roudier J (2008) Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 22:883-896
9. Poole BD, Scofield RH, Harley JB, James JA (2006) Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 39:63-70
10. Origgi L, Hu C, Bertetti E et al (1988) Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome. Boll Ist Sieroter Milan 67:265-274
11. Yamaoka K, Miyasaka N, Yamamoto K (1988) Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndrome. Arthritis Rheum 31:1014-1021
12. Miyasaka N, Yamaoka K, Tateishi M, Nishioka K, Yamamoto K (1989) Possible involvement of Epstein-Barr virus (EBV) in polyclonal B-cell activation in Sjögren's syndrome. J Autoimmun 2:427-432
13. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F (1991) Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med 90:286-294
14. Perrot S, Calvez V, Escande JP, Dupin N, Marcelin AG (2003) Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers. J Clin Virol 28:165-168
15. Pflugfelder SC, Crouse C, Pereira I, Atherton S (1990) Amplification of Epstein-Barr virus genomic sequences in blood cells, lacrimal glands, and tears from primary Sjögren's syndrome patients. Ophthalmology 97:976-984
16. Newkirk MM, Shiroky JB, Johnson N et al (1996) Rheumatic disease patients, prone to Sjögren's syndrome and/or lymphoma, mount an antibody response to BHRF1, the Epstein-Barr viral homologue of BCL-2. Br J Rheumatol 35:1075-1081
17. Yang EV, Webster Marketon JI, Chen M, Lo KW, Kim SJ, Glaser R (2010) Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression. Brain Behav Immun 24:1089-1096
18. Feng WH, Cohen JI, Fischer S et al (2004) Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst 96:1691-1702
19. Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. Ann Rheum Dis 69:1103-1109
20. Mitchell JL, Doyle CM, Land MV, Devine PL (1998) Comparison of commercial ELISA for detection of antibodies to the viral capsid antigen (VCA) of Epstein-Barr virus (EBV). Dis Markers 13:245-249
21. De Paschale M, Cagnin D, Cerulli T et al (2010) Search for anti-EA(D) antibodies in subjects with an "isolated VCA IgG" pattern. Int J Microbiol 2010:1-4
22. Berini CA, Susana Pascuccio M, Bautista CT et al (2008) Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2. J Virol Methods 147:322-327
23. Esparza RH, Swaak T, Aarden L, Smeenk R (1985) Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal. J Rheumatol 12:1109-1117
24. Mahler M, Stinton LM, Fritzler MJ (2005) Improved serological differentiation between systemic lupus erythematosus and mixed connective tissue disease by use of a SmD3 peptide-based immunoassay. Clin Diagn Lab Immunol 12:107-113
25. Ruiz-Tíscar JL, López-Longo FJ, Sánchez-Ramón S et al (2005) Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome. Ann N Y Acad Sci 1050:210-216
26. Goeldner I, Skare TL, de Messias Reason IT, Nisihara RM, Silva MB, Utiyama SR (2010) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil. Rheumatology (Oxford) 49:1590-1593
27. Bakker AJ, Slomp J, de Vries T et al (2003) Adequate sampling in cryoglobulinaemia: recommended warmly. Clin Chem Lab Med 41:85-89
28. Harris EN, Pierangeli S (1991) The anticardiolipin ELISA test. Clin Immunol Newsletter 11:33-44
29. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
30. Haeri S, Baker AM, Boggess KA (2010) Prevalence of Epstein-Barr virus reactivation in pregnancy. Am J Perinatol 27:715-719
31. Macsween KF, Crawford DH (2003) Epstein-Barr virus-recent advances. Lancet Infect Dis 3:131-140
32. Quinlivan EB, Holley-Guthrie EA, Norris M, Gutsch D, Bachenheimer SL, Kenney SC (1993) Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res 21:1999-2007
33. National Center for Infectious Diseases, Centers for Disease Control and Prevention (2006) Epstein-Barr virus and infectious mononucleosis. www.cdc.gov/ncidod/diseases/ebv.htm. Updated: 05/16/2006. The web page has been accessed in October/2011
34. Glaser R, Strain EC, Tarr KL, Holliday JE, Donnerberg RL, Kiecolt-Glaser JK (1985) Changes in Epstein-Barr virus antibody titers associated with aging. Proc Soc Exp Biol Med 179:352-355
35. Wagner HJ, Hornef M, Teichert HM, Kirchner H (1994) Sex difference in the serostatus of adults to the Epstein-Barr virus. Immunobiology 190:424-429
36. Parks CG, Cooper GS, Hudson LL et al (2005) Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 52:1148-1159
37. de-Thé G (1976) Epstein-Barr virus behavior in different populations and implications for control of Epstein-Barr virus-associated tumors. Cancer Res 36:692-695
38. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85-89
39. Zandman-Goddard G, Berkun Y, Barzilai O et al (2009) Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 1173:658-663
40. Esen BA, Yilmaz G, Uzun S et al (2012) Serologic response to Epstein-Barr virus antigen in patients with systemic lupus erythematosus: a controlled study. Rheumatol Int 32:79-83
41. Harley JB, Harley IT, Guthridge JM, James JA (2006) The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 15:768-777
42. Kuwana Y, Takei M, Yajima M et al (2011) Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS One 6: e26630 (Epub 2011 Oct 19)
43. Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 344:1116-1119
44. Mariette X, Agbalika F, Zucker-Franklin D et al (2000) Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjögren's syndrome and other diseases of the oral cavity. Clin Exp Rheumatol 18:341-347
45. Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB (1997) Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg 57:142-148
46. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S (1993) Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 137:43-48